Rallybio Corp announced its financial results for the quarter and year ended December 31, 2022, and the achievement of clinical proof-of-concept in a Phase 1b study for RLYB212.
AI Assistant
RALLYBIO CORP
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.